Medicare Enrolled
Dr. James Meaglia, M.D.
Optician · Laguna Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Meaglia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meaglia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Meaglia
Dr. James Meaglia is an optician specialist in Laguna Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Meaglia performed 4,034 Medicare services across 2,717 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meaglia received a total of $6,166 from 34 pharmaceutical and/or device companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meaglia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in CA
$6,166 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,034
Medicare services
Top 22% in CA for optician
2,717
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~212 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
947 | $2 | $6 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
870 | $9 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
634 | $101 | $420 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
426 | $74 | $298 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
190 | $20 | $85 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
143 | $213 | $832 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $126 | $543 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
83 | $94 | $377 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
64 | $0 | $1 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
59 | $65 | $260 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
53 | $832 | $3,459 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $12 | $48 |
| Transrectal ultrasound of prostate An ultrasound imaging procedure where a probe is inserted into the rectum to create pictures of the prostate gland. |
44 | $160 | $599 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
36 | $87 | $368 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
31 | $8 | $47 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
27 | $49 | $210 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $68 | $252 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
20 | $100 | $533 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
20 | $339 | $1,288 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $342 | $1,268 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $27 | $214 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
19 | $180 | $676 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
19 | $179 | $665 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $129 | $713 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $149 | $554 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $219 | $816 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $53 | $197 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $44 | $188 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $1,210 | $4,484 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
11 | $1,585 | $5,886 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $111 | $435 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
29.1% medium
69.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,166
Total received (2018-2024)
Avg $881/year across 7 years
Top 20% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
280
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,166 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$708
2023
$820
2022
$2,459
2021
$877
2020
$269
2019
$608
2018
$425
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Antares Pharma, Inc.
$176
ABBVIE INC.
$156
Sumitomo Pharma America, Inc.
$105
Olympus America Inc.
$96
Teleflex LLC
$72
ACCORD HEALTHCARE, INC.
$24
Telix Pharmaceuticals
$24
UROGEN PHARMA, INC.
$21
Ferring Pharmaceuticals Inc.
$20
Boston Scientific Corporation
$15
Top 3 companies account for 61.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$2,452
Olympus America Inc.
$438
PROCEPT BioRobotics Corporation
$377
Antares Pharma, Inc.
$352
Astellas Pharma US Inc
$331
ABBVIE INC.
$250
Boston Scientific Corporation
$227
BOSTON SCIENTIFIC CORPORATION
$226
PFIZER INC.
$210
Sumitomo Pharma America, Inc.
$178
Myovant Sciences Inc.
$103
Allergan, Inc.
$99
AbbVie, Inc.
$89
Janssen Biotech, Inc.
$84
KARL STORZ Endoscopy-America
$75
UroGen Pharma, Inc.
$71
Tolmar, Inc.
$70
Travere Therapeutics, Inc.
$61
Allergan Inc.
$55
Kowa Pharmaceuticals America, Inc.
$47
AbbVie Inc.
$45
Axonics, Inc.
$45
C. R. Bard, Inc. & Subsidiaries
$35
NxThera, Inc.
$28
PALETTE LIFE SCIENCES, INC.
$26
Rochester Medical Corporation
$26
ACCORD HEALTHCARE, INC.
$24
Telix Pharmaceuticals
$24
UROVANT SCIENCES INC
$22
Endo Pharmaceuticals Inc.
$21
UROGEN PHARMA, INC.
$21
Ferring Pharmaceuticals Inc.
$20
Curium US LLC
$19
Novo Nordisk Inc
$15
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ADSTILADRIN · ADVANCE · AQUABEAM ROBOTIC SYSTEM · AVEED · Advantage System · Axonics · BOTOX · CAMCEVI · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · Erleada · FLEXIBLE VIDEO URETHRO-CYSTOSCOPE · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL BPH · ILLUCCIX · JELMYTO · LUPRON DEPOT · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · ORGOVYX · Olympus Digital Flexible Ureteroscopes · Olympus Stents · Ozempic · PREMARIN · REZUM · Rezum · Rezum Generator · Seglentis · ShockPulse - SE · TESTOPEL · TOVIAZ · Thiola · UGN Laser Capital · URETERO-RENO-FIBERSCOPE FLEX-X · UROLIFT · UroLift 2 System · UroLift ATC System · UroLift System · XTANDI · XYOSTED · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
606
Per 100K population
19.2
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Meaglia is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Meaglia experienced with automated urinalysis?
Based on Medicare claims data, Dr. Meaglia performed 947 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Meaglia receive payments from pharmaceutical companies?
Yes. Dr. Meaglia received a total of $6,166 from 34 companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meaglia's costs compare to other opticians in Laguna Hills?
Dr. Meaglia's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meaglia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Laguna Hills
Browse opticians in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Olympus America Inc. Payments to Doctors
See all physicians who received payments from Olympus America Inc.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology